Peptides / Brain and mood
Undefined product
Adamax
Not approved
Adamax is a research product name linked to Semax, and sources describe its chemical makeup in conflicting ways. It is not approved, and no published study in PepBank tests it. PepBank shows no results on Adamax from studies in people, animals, the lab or computer predictions. Data as of 2026-10-30.
Also known as Adamax peptide
Evidence level: No study results yetPepBank has no study results for Adamax yet.
Results in people
0
0% of 0 results
Results in animals
0
0% of 0 results
Results in lab cells
0
0% of 0 results
From computer models
0
0% of 0 results
Overview
Adamax at a glance
| What it is | Undefined product |
|---|---|
| Approval | Not approved for any use |
| In sport | Status unknown |
| Studies | No study results for Adamax yet |
| Clinical trials | None registered |
| Community use | Community cognitive use |
The science
What is Adamax?
Semax-related research product name with conflicting chemical identity descriptions.
Adamax structure and chemistry
The key facts about the molecule. Long codes are in the closed section below.
Structure
Adamax is a undefined product, with no ring, no changed amino acids.
Development
Highest phase: no known clinical development.
The evidence
What Adamax studies show
Results grouped by what the studies measured. Each card shows where its results come from.
No study results yetPepBank has no study results for Adamax yet.
Key Adamax studies
No study of Adamax has results in PepBank yet.
Adamax clinical trials
ClinicalTrials.gov lists no trial of Adamax. A trial under another name may exist.
Status and safety
Is Adamax approved?
FDA
United States
Not approvedNo approved medicine contains it.
EMA
European Union
Not approvedNo approved medicine contains it.
WADA
Sport
Not recordedStatus unknown.
No. Not approved for any use. The sources we use show no clinical development. They show no approval at the FDA, the EMA or elsewhere (as of 13 Oct 2026). Status unknown.
Laws and labels change, so check the regulator for the current status.
Adamax side effects and safety
PepBank has no safety result from studies of Adamax yet. That does not mean Adamax is safe.
From the community
How people use it
What people report online. It comes from forums and guides, not from studies.
Community-reported. Not tested in trials.
The source reports this use pattern. It does not establish safety or efficacy.
Reported routines and cautions
What people use it for
- Community cognitive useS1
Reported regimens
| Context | Route | Amount | How often | How long | Agreement | Sources |
|---|---|---|---|---|---|---|
| Community cognitive use | nasal or injection | 100 to 300 mcg per dose | once daily or every other day | 2 to 4 weeks, then a break | single source | S1 |
Community sources
Gaps
Only a secondary guide supports this regimen. The guide does not name its underlying reports or sellers. Actual community use, product identity and purity remain unresolved. No Adamax manufacturer label regimen was identified.
Questions and more
Ask a question about Adamax
The answer links to every study it uses.
Sources
- Database: PepBank data for Adamax (data version 308560)
- Regulator: FDA status record
- Regulator: EMA status record
- Regulator: WADA status record
- Community: community sources (forums and guides), as summarized in the PepBank community file
AI wrote and checked these results. AI can make mistakes, so check important results against the source.
PepBank is a research reference. Talk to a doctor before you use any peptide.
Ask your AI about Adamax
Curo is a peptide shop. PepBank and Curo have the same owner. See the Curo catalog (opens in a new tab).